Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma.

Imaging features showing aggressive tumour biology and poor liver function, in addition to clinical parameters, can serve as imaging biomarkers for OS and LD in patients receiving sorafenib and selective internal radiation therapy for HCC.